ClinicalTrials.Veeva

Menu

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

G

Ghent University Hospital (UZ)

Status and phase

Completed
Phase 2

Conditions

Critically Ill Patients

Treatments

Drug: to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.

Study type

Interventional

Funder types

Other

Identifiers

NCT00288743
2002/087

Details and patient eligibility

About

There is a growing body of evidence in the literature regarding the adverse effects of hyperglycemia in critically ill patients. To target and maintain better blood glucose regulation we implemented an insulin protocol with target blood glucose levels between 81-110 mg/dL.

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Surgical or medical critically ill patients
  • An expected ICU-stay of more than 72 hours
  • Age > 16 years
  • Need for insulin therapy
  • Patients must have an arterial line

Exclusion criteria

  • Patients who did not respond to the inclusion criteria
  • Patients with diabetic ketoacidosis
  • Cardiac surgical patients
  • Patients transferred from other hospitals
  • Other study enrollment

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems